Archives

by in
Entry Author Date Location
PowerInbox Merges with ActivePath, Looks to Push Interactive E-mail 11/27/12 Boston
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug 11/06/12 San Diego
Ambit Biosciences Obtains $50,000,000 New Funding 11/06/12 San Diego
Histogenics Obtains $49,000,000 Series A Funding 07/24/12 Boston
Histogenics Receives $49,000,000 Series A Round 07/24/12 Boston
ActivePath Garners $10,000,000 New Funding 09/20/11 New York
Ambit Raises $30M Venture Round, After Pulling Plug on IPO 06/10/11 San Diego
Ambit Biosciences Receives $30,000,000 Series D Funding Round 06/10/11 San Diego
Ambit Bio Raises $15M 10/19/10 San Diego
Promising Skin Cancer Drug Could Be First Big Win for Plexxikon’s Structure-Based Drug Discovery Approach 08/26/10 San Francisco
Nereus Pharmaceuticals Receives $20,000,000 New Financing 06/23/10 San Diego
VirtenSys Raises $16M 08/11/09 Seattle
VirtenSys Obtains $16,000,000 Series C Financing Round 08/11/09 Seattle
ChemoCentryx Receives $29,840,000 Series D Funding Round 03/22/07 San Francisco
Page 1 of 1